HIGHLIGHTS
- who: Stefanie Schreiber from the Department of Neurology, Otto von Guericke University, Leipziger Strasse, Magdeburg, Germany have published the article: Counteraction of inflammatory activity in CAA-related subarachnoid hemorrhage, in the Journal: (JOURNAL) of 13/09/2022
- how: The authors therefore decided to counteract high CAA disease and suspected inflammatory activity in the presented patient through systemic high-dose methyl prednisolone (MP) 1 g daily for 3 days which was initiated immediately after MRI MP is frequently applied in CAA-ri but so far not in clinical use for the more common noninflammatory forms of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.